Literature DB >> 30104296

Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study.

Julia A Critchley1, Iain M Carey2, Tess Harris2, Stephen DeWilde2, Fay J Hosking2, Derek G Cook2.   

Abstract

OBJECTIVE: Diabetes mellitus (DM) increases the risk of infections, but the effect of better control has not been thoroughly investigated. RESEARCH DESIGN AND METHODS: With the use of English primary care data, average glycated hemoglobin (HbA1c) during 2008-2009 was estimated for 85,312 patients with DM ages 40-89 years. Infection rates during 2010-2015 compiled from primary care, linked hospital, and mortality records were estimated across 18 infection categories and further summarized as any requiring a prescription or hospitalization or as cause of death. Poisson regression was used to estimate adjusted incidence rate ratios (IRRs) by HbA1c categories across all DM, and type 1 and type 2 DM separately. IRRs also were compared with 153,341 age-sex-practice-matched controls without DM. Attributable fractions (AF%) among patients with DM were estimated for an optimal control scenario (HbA1c 6-7% [42-53 mmol/mol]).
RESULTS: Long-term infection risk rose with increasing HbA1c for most outcomes. Compared with patients without DM, those with DM and optimal control (HbA1c 6-7% [42-53 mmol/mol], IRR 1.41 [95% CI 1.36-1.47]) and poor control (≥11% [97 mmol/mol], 4.70 [4.24-5.21]) had elevated hospitalization risks for infection. In patients with type 1 DM and poor control, this risk was even greater (IRR 8.47 [5.86-12.24]). Comparisons within patients with DM confirmed the risk of hospitalization with poor control (2.70 [2.43-3.00]) after adjustment for duration and other confounders. AF% of poor control were high for serious infections, particularly bone and joint (46%), endocarditis (26%), tuberculosis (24%), sepsis (21%), infection-related hospitalization (17%), and mortality (16%).
CONCLUSIONS: Poor glycemic control is powerfully associated with serious infections and should be a high priority.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30104296     DOI: 10.2337/dc18-0287

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  83 in total

Review 1.  Dissecting the interaction between COVID-19 and diabetes mellitus.

Authors:  Ying Jie Chee; Seng Kiong Tan; Ester Yeoh
Journal:  J Diabetes Investig       Date:  2020-08-05       Impact factor: 4.232

2.  COVID-19 and diabetes: What have we learned so far?

Authors:  Nida Taher; Mohammed Sb Huda; Tahseen A Chowdhury
Journal:  Clin Med (Lond)       Date:  2020-05-22       Impact factor: 2.659

3.  Increased incidence of genital warts among women and men with type 1 diabetes compared with the general population-results from a nationwide registry-based, cohort study.

Authors:  K Reinholdt; C Munk; L T Thomsen; C Dehlendorff; B Carstensen; M E Jørgensen; S K Kjaer
Journal:  Acta Diabetol       Date:  2021-09-09       Impact factor: 4.280

4.  Sleeve Gastrectomy Ameliorates Diabetes-Related Spleen Damage by Improving Oxidative Stress Status in Diabetic Obese Rats.

Authors:  Minggang Wang; Yacheng Xiong; Wei Zhu; Rexiati Ruze; Qian Xu; Zhibo Yan; Jiankang Zhu; Mingwei Zhong; Yugang Cheng; Sanyuan Hu; Guangyong Zhang
Journal:  Obes Surg       Date:  2020-10-26       Impact factor: 4.129

Review 5.  Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach.

Authors:  Shilpi Kashyap; Rajni Bala; Reecha Madaan; Tapan Behl
Journal:  Environ Sci Pollut Res Int       Date:  2021-05-21       Impact factor: 4.223

Review 6.  COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.

Authors:  Cyril P Landstra; Eelco J P de Koning
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

Review 7.  Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review.

Authors:  Amany Magdy Beshbishy; Victor B Oti; Diaa E Hussein; Ibrahim F Rehan; Oluyomi S Adeyemi; Nallely Rivero-Perez; Adrian Zaragoza-Bastida; Muhammad Ajmal Shah; Khaled Abouelezz; Helal F Hetta; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Front Public Health       Date:  2021-07-07

8.  Effectiveness of a multifaceted prevention programme for melioidosis in diabetics (PREMEL): A stepped-wedge cluster-randomised controlled trial.

Authors:  Pornpan Suntornsut; Prapit Teparrukkul; Gumphol Wongsuvan; Wipada Chaowagul; Susan Michie; Nicholas P J Day; Direk Limmathurotsakul
Journal:  PLoS Negl Trop Dis       Date:  2021-06-25

9.  Glycosylated Hemoglobin as a Predictor of Sepsis and All-Cause Mortality in Trauma Patients.

Authors:  Feng Guo; Haitao Shen
Journal:  Infect Drug Resist       Date:  2021-07-01       Impact factor: 4.003

Review 10.  Trending Technology of Glucose Monitoring during COVID-19 Pandemic: Challenges in Personalized Healthcare.

Authors:  Le Minh Tu Phan; Thuy Anh Thu Vo; Thi Xoan Hoang; Sathish Panneer Selvam; Hoang Lan Pham; Jae Young Kim; Sungbo Cho
Journal:  Adv Mater Technol       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.